Contact this trialFirst, we need to learn more about you.
Serotonin–norepinephrine–dopamine reuptake inhibitor
Liafensine for Treatment Resistant Depression
Recruiting0 awardsPhase 2
Miami, Florida
This trial will study a new treatment for depression in people who haven't responded well to other treatments. Around 180 people will be randomly assigned to receive either the new treatment or a placebo. Neither the participants nor the researchers will know who is receiving which until the end of the trial.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.